More on abt
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $100.10 |
|
|||
| Open | $100.56 | ||||
| 52 Wk High | $46.38 | ||||
| 52 Wk Low | $36.00 | ||||
| Day High | $100.95 | ||||
| Day Low | $99.90 | ||||
| P/E | 66.65 | ||||
| EPS | $1.50 | ||||
| Volume | 505,179 | ||||
- FDA clears Abbott CardioMEMS app features for heart failure patients
- Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
- Form 4 ABBOTT LABORATORIES For: Sep 30 Filed by: Stratton John G
- Form 4 ABBOTT LABORATORIES For: Sep 30 Filed by: Gonzalez Patricia Paola
- Form 4 ABBOTT LABORATORIES For: Sep 30 Filed by: Conroy Kevin T
- Form 4 ABBOTT LABORATORIES For: Sep 30 Filed by: Ahuja Nita
- Form 4 ABBOTT LABORATORIES For: Sep 30 Filed by: Roman Michael F
- Rothschild Redburn Upgrades Abbott Labs (ABT) to Buy
- Abbott hosts conference call for third-quarter earnings
- Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
Entities mentioned with ABT
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
